RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications
American Entrepreneurship
JUNE 6, 2023
LRVHealth, McKesson Ventures, Novartis, Hearst Ventures, Onco360, and HealthX Ventures Join Investment Round to Redefine Specialty Patient Access and Onboarding NEW ALBANY, Ind.– RxLightning , creator of the industry’s first comprehensive platform for streamlining specialty medication access and affordability, today announced that it closed a $17.5 million Series A investment to support the company’s growth and further remove barriers to life-saving therapies.
Let's personalize your content